Abstract
Objectives
To investigate the long-term clinical and imaging outcomes of patients with chondroblastoma treated by radiofrequency ablation (RFA).
Methods
Retrospective analysis of 25 consecutive patients treated with RFA from September 2006 to December 2013. Patients were reviewed within one month of the procedure, then every 3-6 months, and yearly for up to three years. Serial magnetic resonance imaging (MRI) was performed at follow-up to monitor recovery. Functional outcome was assessed using the Musculoskeletal Tumour Society Score (MSTS).
Results
Pre-procedure MRI confirmed osteolytic lesions (size range 1.0-3.3 cm; mean 2.0 cm). Patients reported continued symptomatic improvement at four months review. Serial MRI confirmed progressive resolution of inflammation with fatty consolidation of cavity. 88 % of patients became asymptomatic during the follow up period. Three patients’ (12 %) symptoms returned at 16, 22 and 24 months respectively after RFA. MRI and biopsy confirmed recurrence in these patients. Functional assessment using MSTS score had an average score of 97.5 %. Mean follow up for the study group was 49 months.
Conclusion
RFA is an effective alternative to surgery in the management of chondroblastoma. We recommend a multi-disciplinary approach and RFA should be considered as a first-line treatment. Long-term follow-up is required for timely detection of recurrences.
Key Points
• RFA is a safe and effective technique in the treatment of chondroblastoma.
• Positive outcomes in 88 % patients at mean follow-up period of 49 months.
• Local recurrences occurred in 12 % cases.
• Long-term follow-up is required for timely detection of recurrences.
• RFA should be considered as a first-line treatment for chondroblastoma.
Similar content being viewed by others
References
Jaffe HL, Lichtenstein L (1942) Benign chondroblastoma of bone: a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am J Pathol 18:969–991
Ramappa AJ, Lee FY, Tang P, Carlson JR, Gebhardt MC, Mankin HJ (2000) Chondroblastoma of bone. J Bone Joint Surg Am 82-A:1140–1145
Springfield DS, Capanna R, Gherlinzoni F, Picci P, Campanacci M (1985) Chondroblastoma. A review of seventy cases. J Bone Joint Surg Am 67:748–755
Bloem JL, Mulder JD (1985) Chondroblastoma: a clinical and radiological study of 104 cases. Skelet Radiol 14:1–9
Santiago FR, Del Mar Castellano Garcia M, Montes JL, Garcia MR, Fernandez JM (2009) Treatment of bone tumours by radiofrequency thermal ablation. Curr Rev Musculoskelet Med 2:43–50
Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Wong GY, Sloan JA et al (2002) Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 224:87–97
Cioni R, Armillotta N, Bargellini I, Zampa V, Cappelli C, Vagli P et al (2004) CT-guided radiofrequency ablation of osteoid osteoma: long-term results. Eur Radiol 14:1203–1208
Erickson JK, Rosenthal DI, Zaleske DJ, Gebhardt MC, Cates JM (2001) Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: report of three cases. Radiology 221:463–468
Tins B, Cassar-Pullicino V, McCall I, Cool P, Williams D, Mangham D (2006) Radiofrequency ablation of chondroblastoma using a multi-tined expandable electrode system: initial results. Eur Radiol 16:804–810
Petsas T, Megas P, Papathanassiou Z (2007) Radiofrequency ablation of two femoral head chondroblastomas. Eur J Radiol 63:63–67
Christie-Large M, Evans N, Davies AM, James SL (2008) Radiofrequency ablation of chondroblastoma: procedure technique, clinical and MR imaging follow up of four cases. Skelet Radiol 37:1011–1017
Rybak LD, Rosenthal DI, Wittig JC (2009) Chondroblastoma: radiofrequency ablation—alternative to surgical resection in selected cases. Radiology 251:599–604
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286:241–246
Atalar H, Basarir K, Yildiz Y, Erekul S, Saglik Y (2007) Management of chondroblastoma: retrospective review of 28 patients. J Orthop Sci 12:334–340
Lin PP, Thenappan A, Deavers MT, Lewis VO, Yasko AW (2005) Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res 438:103–109
Lalam RK, Cribb GL, Tins BJ, Cool WP, Singh J, Tyrrell PN et al (2014) Image guided radiofrequency thermo-ablation therapy of chondroblastomas: should it replace surgery? Skelet Radiol 43:513–522
Geiger D, Napoli A, Conchiglia A, Gregori LM, Arrigoni F, Bazzocchi A et al (2014) MR-guided focused ultrasound (MRgFUS) ablation for the treatment of nonspinal osteoid osteoma: a prospective multicenter evaluation. J Bone Joint Surg Am 96:743–751
Coupal TM, Mallinson PI, Munk PL, Liu D, Clarkson P, Ouellette H (2014) CT-guided percutaneous cryoablation for osteoid osteoma: initial experience in adults. AJR Am J Roentgenol 202:1136–1139
Kostrzewa M, Diezler P, Michaely H, Rathmann N, Attenberger UI, Schoenberg SO et al (2014) Microwave ablation of osteoid osteomas using dynamic MR imaging for early treatment assessment: preliminary experience. J Vasc Interv Radiol 25:106–111
Roqueplan F, Porcher R, Hamze B, Bousson V, Zouari L, Younan T et al (2010) Long-term results of percutaneous resection and interstitial laser ablation of osteoid osteomas. Eur Radiol 20:209–217
Acknowledgments
The scientific guarantor of this publication is Dr Steven L. J. James, Department of Radiology, The Royal Orthopaedic Hospital Foundation Trust, Bristol Road South, Northfield, Birmingham B31 2AP, UK. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was not required for this study because Institutional Review Board approval for this retrospective service evaluation of outcomes following the procedure did not require written consent for data collection. Approval from the institutional animal care committee was not required because the study did not involve animals. Methodology: retrospective, diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xie, C., Jeys, L. & James, S.L.J. Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes. Eur Radiol 25, 1127–1134 (2015). https://doi.org/10.1007/s00330-014-3506-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3506-1